MedPath

Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)

Completed
Conditions
Brain Injury
Registration Number
NCT02003196
Lead Sponsor
Nantes University Hospital
Brief Summary

Morbidity and mortality of ICU patients is increased by the development of a "immunosuppression" systemic (IS). This IS develops in the early hours of hospitalization and is responsible for severe infections, including viral reactivations (Cytomegalovirus or Herpes Simplex Virus). Viral reactivation was associated with increased morbidity and mortality in intensive care units. In clinical practice, they are searched at the onset of organ failure or unexplained fever. The investigators wish to conduct this research in the stroke patients to assess the predictive power of these viral reactivations on the duration of mechanical ventilation.

Detailed Description

PCR for herpes simplex virus in blood and in tracheal aspirate (Day-1, Day-7 and Day-15) - clinicians are blinded to the results PCR for Cytomegalovirus in blood and in tracheal aspirate (Day-1, Day-7 and Day-15) - clinicians are blinded to the results

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
375
Inclusion Criteria
  • Hospitalisation in intensive care unit
  • Acute brain injury (trauma, subarachnoid haemorrhage, stroke, infection) with Glasgow Coma Scale <= 12
  • Age between 18 and 75 years
  • Mechanical ventilation > 24 hours
Exclusion Criteria
  • encephalopathy post anoxy
  • active cancer
  • Immunosuppresseur treatment
  • pregnancy
  • history of autoimmune disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ventilatory-free days at day 9090 days
Secondary Outcome Measures
NameTimeMethod
Bacterial hospital acquiered infection28 days
organ failure28 days
hospitalisation length of stay28 days
Mortality28 days and 90 days

Trial Locations

Locations (1)

CHU de Nantes

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath